Ipsen – November 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares composing…
Abstract and Open World Partner to Launch the First National-Scale Tokenization Engine for the World’s Most Valuable Real-World Assets
For the first time, the world's most strategic assets—AI supercomputing centers, strategic…
VELO AND THE McLAREN FORMULA 1 TEAM’S FAN-DESIGNED LIVERY TAKES CENTRE STAGE AS LANDO NORRIS WINS 2025 DRIVERS’ CHAMPIONSHIP IN ABU DHABI
ABU DHABI, UAE, Dec. 8, 2025 /PRNewswire/ -- Yesterday, the McLaren Formula 1®…
The Acceleration Continues: Vetty Named One of Nucleus Researchs Hot Companies to Watch in 2026
AUSTIN, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Vetty, the one-stop shop…
Global Stars Confirmed as the Games of the Future Abu Dhabi 2025 Finalises Full Line-Up
Some of the biggest names in phygital sports and esports from around…
The 4th China International Supply Chain Expo Set for Beijing in June 2026
Sustained Worldwide Outreach Drives Greater Collaboration OpportunitiesBEIJING, Dec. 7, 2025 /PRNewswire/ -- …
Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition
93% overall response and 76% complete response rates with median progression-free survival…
Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
December 07, 2025 16:00 ET | Source: Wave Life Sciences USA, Inc.…
TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 06, 2025 17:30 ET | Source: TScan Therapeutics, Inc. Treatment arm…
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 06, 2025 17:30 ET | Source: Fulcrum Therapeutics, Inc. ― Clear…
